NEUE (NeueHealth) ROCE %: 0.00% (As of Jun. 2025)


NEUE NeueHealth Inc NEUE
20 GF Score
Price $6.75
GF Value $8.81
! 6 Warning Signs
View Full Analysis

What is NeueHealth ROCE %?

NeueHealth NEUE 20 ROCE % is 0.00% as of Jun. 2025. GuruFocus rates NEUE with a GF Score™ of 20/100 and a GF Value™ of $8.81. The stock has 6 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. NeueHealth's annualized ROCE % for the quarter that ended in Jun. 2025 was 0.00%.

NeueHealth  (NYSE:NEUE) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

NeueHealth ROCE % Related Terms

NeueHealth ROCE % Historical Data

* Premium members only.

The historical data trend for NeueHealth's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NeueHealth ROCE % Chart

NeueHealth Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROCE %
Get a 7-Day Free Trial -18.21 -26.75 -32.25 -146.62 0.00

NeueHealth Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NEUE
20GF Score
NeueHealth Inc NEUE
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NeueHealth ROCE % Calculation

NeueHealth's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=-80.76/( ( (1225.48 - 1391.257) + (544.383 - 710.228) )/ 2 )
=-80.76/( (-165.777+-165.845)/ 2 )
=-80.76/-165.811
=48.71 %

NeueHealth's ROCE % of for the quarter that ended in Jun. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Jun. 2025 )  (Q: Mar. 2025 )(Q: Jun. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Jun. 2025 )  (Q: Mar. 2025 )(Q: Jun. 2025 )
=54.78/( ( (895.68 - 1064.052) + (743.689 - 908.412) )/ 2 )
=54.78/( ( -168.372 + -164.723 )/ 2 )
=54.78/-166.5475
=0 %

(1) Note: The EBIT data used here is four times the quarterly (Jun. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 0.00% mean?
NeueHealth (NEUE) has a ROCE % of 0.00% as of Jun. 2025.
Is NeueHealth's ROCE % too high?
NeueHealth's current ROCE % is 0.00%. Overall, NeueHealth has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does NeueHealth's ROCE % compare to PFHO and UNH?
NeueHealth's ROCE % of 0.00% can be compared against companies in the Healthcare Plans industry. The industry median ROCE % is 9.38. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Plans company?
The median ROCE % among Healthcare Plans companies is 9.38, based on 15 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Plans industry, the median ROCE % is 9.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NeueHealth's current ROCE % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NeueHealth stock overvalued right now?
NeueHealth (NEUE) has a current ROCE % of 0.00%. The stock's GF Value™ is $8.81, compared to a current price of $6.75 — trading 23.3% below its estimated fair value. The current ROCE % is 0.00%. NeueHealth's overall GF Score™ is 20/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For NeueHealth (NEUE), the current ROCE % is 0.00% as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is NeueHealth (NEUE) Overvalued in 2026?

Based on GuruFocus' analysis, NeueHealth stock appears to be undervalued. The current stock price of $6.75 is trading 23.3% below its estimated GF Value™ of $8.81.

Key valuation signals for NEUE:

  • ROCE %: 0.00%
  • GF Value™: $8.81 vs. price of $6.75 (23.3% below fair value)
  • GF Score™: 20/100 with 6 warning signs

No single metric tells the full story. See the NEUE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

NeueHealth Business Description

Address 9250 NW 36th Street, Suite 420, Doral, FL, USA, 33178
NeueHealth Inc is a value-driven healthcare company grounded in the belief that all health consumers are entitled to high-quality, coordinated healthcare. It consists of two reportable segments: NeueCare - it's a value-driven care delivery business that manages risk in partnership with external payors and serves all populations across The Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act. NeueSolutions - it's a provider enablement business that includes a suite of technology, services, and clinical care solutions that empower providers to thrive in performance-based arrangements.
20GF Score

Get the complete analysis for NEUE

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.75
Price
$8.81
GF Value